News | Catheters | July 02, 2026

Penumbra Receives CE Mark for Reperfusion Catheters

The Red 72 Silver Label devices are reperfusion catheters designed for acute ischemic stroke.

Penumbra Receives CE Mark for Reperfusion Catheters

June 30, 2026 — Penumbra Inc. has received the CE Mark for Red 72 Silver Label and Red 72 Silver Label with SENDit Technology, which includes significant updates to Penumbra’s large-bore reperfusion catheter, Red 72.

The Red 72 Silver Label devices are reperfusion catheters designed for acute ischemic stroke. Direct aspiration with Red 72 Silver Label can provide a fast, frontline option for acute ischemic stroke. The COMPASS Trial has shown aspiration catheters to be equal to stent retrievers in first pass success.1

Developed for speed and ease of navigation, the new Red 72 Silver Label features meticulously blended transition zones to better accommodate the natural anatomy of the brain. Adapted from the popular Red 43 and Red 62 catheters, the Red 72 Silver Label features Penumbra’s latest engineering enhancements.

The new Red 72 Silver Label with SENDit Technology is designed to minimize the ledge effect, simplify preparation, and ease delivery in LVO.

“The introduction of Silver Label is indicative of Penumbra’s commitment to continuous innovation. We have more than 20 years of experience in developing state of the art devices for minimally invasive interventions in the neurovasculature,” said Joan Kristensen, Head of Penumbra EMEA. “We are now launching our most advanced catheter yet, designed for enhanced trackability while maintaining the hallmark lumen integrity of the Red catheter portfolio. This is very exciting, and we are thrilled to see how this latest generation of the Red 72 catheters can help physicians provide world-class stroke care to patients across Europe.”

Red 72 Silver Label was released in the US in April 2025 and has therefore been available to US physicians in the past year.

“Red 72 Silver Label has significantly changed our practice as it pertains to treating patients with LVO. The refined engineering is evident as the catheter tracks distally with ease and maintains lumen diameter during aspiration. The catheter construction is state of the art, allowing for faster and safer recanalization of stroke patients with LVO. It is fantastic that our European counterparts now have access to the latest catheter technology,” said Dr. Donald Frei, neurointerventional radiologist at Swedish Medical Center, Denver, USA.

Red 72 Silver Label has a .072″ (1.83 mm) Lumen and a .085″ (2.16 mm) outer diameter. It comes in the length of 132 cm to reach target vessels.

Red 72 Silver Label and Red 72 Silver Label with SENDit technology are available as separate catheters or pre-packaged with Penumbra’s Thunderbolt – the first device with computer-assisted modulated aspiration for stroke care.

 

1. Turk AS 3rd, Siddiqui A, Fifi JT, De Leacy RA, Fiorella DJ, Gu E, Levy EI, Snyder KV, Hanel RA, Aghaebrahim A, Woodward BK, Hixson HR, Chaudry MI, Spiotta AM, Rai AT, Frei D, Almandoz JED, Kelly M, Arthur A, Baxter B, English J, Linfante I, Fargen KM, Mocco J. Aspiration thrombectomy versus stent retriever thrombectomy as first-line approach for large vessel occlusion (COMPASS): a multicentre, randomised, open label, blinded outcome, non-inferiority trial. Lancet. 2019 Mar 9;393(10175):998-1008. doi: 10.1016/S0140-6736(19)30297-1. PMID: 30860055

 

Penumbra CE Mark

 


Related Content

News | Cath Lab

June 18, 2026 — Allegheny Health Network's (AHN) Allegheny General Hospital (AGH) has completed a $19 million renovation ...

Home June 18, 2026
Home
News | Cath Lab

May 28, 2026 — RWJBarnabas Health has earned Cardiac Catheterization Lab Accreditation from the American College of ...

Home May 29, 2026
Home
News | Cath Lab

May 13, 2026 — According to a recently released report, the global cath lab services market was valued at $46.0 billion ...

Home May 13, 2026
Home
News | Cath Lab

April 16, 2026 — A national study led by investigators from Cedars-Sinai Health Sciences University found that ...

Home April 20, 2026
Home
News | Cath Lab

April 6, 2026 —Stereotaxis has received U.S. Food and Drug Administration 510(k) clearance for its Synchrony system ...

Home April 07, 2026
Home
News | Cath Lab

March 31, 2026 — Solo Pace Inc. has announced the commercial release of the SoloPace Fusion Temporary Pacing System. The ...

Home April 03, 2026
Home
News | Cath Lab

March 25, 2026 — Royal Philips has launched its intuitive interventional guidance platform, IntraSight Plus, which is ...

Home March 26, 2026
Home
Feature | Cath Lab | Kyle Hardner

Since receiving FDA approval in 2016, intravascular lithotripsy (IVL) systems have grown in popularity among ...

Home November 14, 2025
Home
News | Cath Lab

Nov. 11, 2025 — FastWave Medical has successfully completed enrollment in its 30-patient coronary feasibility study and ...

Home November 13, 2025
Home
News | Cath Lab

Oct. 28, 2025 — Results from the first-of-its-kind randomized PROCTOR trial found that a strategy of saphenous vein ...

Home November 04, 2025
Home
Subscribe Now